Cargando…
Successful Rituximab Therapy for Skin Sclerosis and Myositis in a Patient With Systemic Sclerosis, Myositis and Sjögren’s Syndrome Associated With Autoimmune Polyendocrine Syndrome Type 2
Autoimmune polyendocrine (or polyglandular) syndrome (APS) is a relatively rare clinical condition characterized by functional impairment of multiple endocrine glands due to loss of immune tolerance. APS is broadly categorized as rare monogenic forms, such as autoimmune polyendocrine syndrome type 1...
Autores principales: | Saeki, Takako, Nishiyama, Hiroki, Kimura, Haruna, Usuda, Hiroyuki, Furukawa, Kazuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10593914/ https://www.ncbi.nlm.nih.gov/pubmed/37881380 http://dx.doi.org/10.7759/cureus.45831 |
Ejemplares similares
-
Co-Occurrence of Systemic Lupus Erythematosus and Autoimmune Polyendocrine Syndrome II: Is There a Pathologic Link?
por: Aamer, Sameen, et al.
Publicado: (2020) -
Inclusion body myositis associated with Sjögren’s syndrome
por: Misterska-Skóra, Maria, et al.
Publicado: (2012) -
A case of autoimmune myositis after treatment with alemtuzumab for multiple sclerosis
por: Aouad, Patrick, et al.
Publicado: (2018) -
Scleromyositis: A Novel Entity Beyond Systemic Sclerosis and Autoimmune Myositis
por: Marche Fernandez, Osvaldo Alexis, et al.
Publicado: (2023) -
Refractory Statin-Induced Immune-Mediated Necrotizing Myositis: Challenges and Perils in Its Management
por: Yeo, Chong Hsien, et al.
Publicado: (2022)